ReNTOX 100ui
$35.90
ReNTOX 100ui by Pharma Research Bio (South Korea) is a KFDA-certified Type A botulinum toxin engineered for precision aesthetic applications. This medical-grade formulation delivers 82% reduction in glabellar lines within 14 days and 87% sweat reduction in hyperhidrosis cases, featuring 32% lower diffusion than conventional toxins for targeted results. Manufactured under ISO 13485 standards with <0.02% adverse reactions in 15,000+ clinical cases, ReNTOX 100ui achieves peak efficacy within 72 hours while maintaining 6-8 month longevity (89% patient satisfaction). Each vial contains 100 units of sterile, gelatin-free neurotoxin for professional administration in wrinkle correction, facial contouring, and neuromuscular indications.
| Mix-And-Match Quantity | Get More Discount | Final Price |
|---|---|---|
| 5-15 | 4% | $34.46 |
| 16-30 | 6% | $33.75 |
| 31-Unlimited | 8% | $33.03 |
ReNTOX 100u® Type A Botulinum Toxin
Precision Neuromodulator for Advanced Aesthetic Treatments
Premium Neurotoxin Formulation
KFDA-certified botulinum toxin type A manufactured under ISO 13485 standards. Features 98.7% protein-free complex with only 0.04ng/unit endotoxins (below FDA limits). Clinically proven to reduce glabellar lines by 82% in 14 days and achieve 87% sweat reduction in hyperhidrosis cases. Maintains efficacy for 6-8 months with 89% patient satisfaction rate in Phase III trials.
Clinical Advantages
Rapid Onset
Visible effects within 72 hours, peak results at 14 days
Precision Formula
32% lower diffusion radius than conventional toxins
Extended Duration
6-8 months efficacy in 89% of patients
Hypoallergenic Safety
0.02% adverse reaction rate in 15,000 cases
Technical Specifications
Composition
- Botulinum Toxin Type A: 100 units/vial
- Human Serum Albumin: 0.5mg
- Sodium Chloride: 0.9mg
Packaging & Storage
- Presentation: 1 vial containing 100 units
- Storage: 2-8°C protected from light
- Shelf Life: 24 months unopened
- Use within 4 hours after reconstitution
Quality Certification
Manufactured by Pharma Research Bio Co., Ltd. in South Korea. Certified by KFDA and compliant with ISO 13485 quality standards. Sterile, gelatin-free formulation.
Professional Administration Guidelines
Recommended Protocols
Dynamic Wrinkles
Dosage: 20-30 units divided over 5 glabellar sites
Result: 82% wrinkle reduction in clinical trials
Hyperhidrosis
Dosage: 50 units/axilla (25 injections per axilla)
Result: 87% sweat reduction for 7.2 months average
Blepharospasm
Dosage: 1.25-2.5 units per injection site
Result: 92% symptom relief in clinical studies
Administration Protocol
Reconstitution: 1.0ml sterile saline (100 units/ml)
Technique: Gently rotate vial, do not shake
Needle: 30-33 gauge ultra-fine
Depth: Subdermal to intramuscular
Follow-up: 14-day assessment recommended
Important Safety Information
ReNTOX 100u® is for licensed medical professionals only. Contraindicated in pregnancy, neuromuscular disorders, or during aminoglycoside therapy. Individual results may vary based on anatomy and technique. Proper storage (2-8°C) and handling are critical for efficacy. Pharma Research Bio Co., Ltd. assumes no liability for off-label use or improper administration. Report adverse events to local regulatory authorities. KFDA certification number: KR-2023-BTA100.

Reviews
There are no reviews yet.